SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1286More on Rebif - the SRA press release biz.yahoo.comIRWIN JAMES FRANKEL-5/8/2001
1285Serono Announces Highly Significant Positive Outcome Of Rebif(R) vs Avonex(R) Stnigel bates-5/8/2001
1284<i>Biogen down after news of lower royalty revenue =======================Biomaven-3/28/2001
1283Long multiple sclerosis fight moves to phase III By Phoebe Dey March 20, 2001 -Blaumax-3/22/2001
1282Intron A EXTENDS OVERALL SURVIVAL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH HIGMark Bong-3/14/2001
1281Harold, As I pointed out on the Valuation thread, the CSFB rating is likely theBiomaven-2/14/2001
1280I haven't kept track of upgrades and downgrades, but those things should be Harold Engstrom-2/14/2001
1279CSFB track record with BGEN looks pretty bad. Harold, CSFB downgraded BGEN on 1Mark Bong-2/14/2001
1278Credit Suisse analyst Meirav Chovav has apparently put a one year price target oHarold Engstrom-2/14/2001
1277Biogen up 14.26% for the week. In general the mature biotech companies did well blackmerlin-2/11/2001
1276Conference in March. BGEN probably will be presenting also. March 2001 aknahow-2/5/2001
1275Thanks, the presenter also said that they think Amevive will be a billion dollaraknahow-2/5/2001
1274I tend to agree with you. The presenter was a replacement. I don't always aknahow-2/5/2001
1273George, BGEN has said that the average time until retreatment is about 8 months.Mark Bong-2/5/2001
1272George, WRT capacity, I suspect that no one really knows what any particular coHarold Engstrom-2/4/2001
1271The VGEN presentation at Piper Jaffray ws quite interesting. You posted, "aknahow-2/4/2001
1270BGEN stated that 25% of psoriasis patients had complete clearance of disease, anMark Bong-2/1/2001
1269Secondary Progressive Multiple Sclerosis New Study with Biogen's AVONEX(R) Mark Bong-1/16/2001
1268IDEC-PHARMACEUTICALS)(IDPH) IDEC Pharmaceuticals Begins Phase II Study in Immunescaram(o)uche-1/4/2001
1267finance.yahoo.com Nice to see them staying on the cutting edge.tommysdad-12/19/2000
1266pb, as of today,the national psoriasis foundation has a new website with a listsoftware salesperson-12/19/2000
12651: J Exp Med 2000 Jul 3;192(1):129-35 Related Articles, Books, LinkOut BAFF bkeokalani'nui-12/8/2000
1264: Nat Med 2000 Nov;6(11):1241-7 Related Articles, Books, LinkOut Deficiency ikeokalani'nui-12/8/2000
1263AMGN, DNA, BGEN, HGSI, ZymoGenetics, and who knows who else, this one is going tscaram(o)uche-10/18/2000
1262New England Journal of Medicine Study Reports That Biogen's Avonex(R) (IntMark Bong-9/25/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News